Screening in arterial disease: ethical and methodological issues P Lacroix and V Aboyans.

Slides:



Advertisements
Similar presentations
Extent of Problem 66,000 adults & children in NI with diabetes Estimates of ca 12,500 people who are as yet unaware that they have the condition.
Advertisements

Screening and Prevention
Screening & Prevention AK Nayyar. Prevention Primary Secondary Tertiary.
Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
You have to provide a laboratory service for a Caucasian population of 3 million. How would you go about this? Describe your strategy for staff and equipment.
Lecture 3 Validity of screening and diagnostic tests
Prevention and Screening MMS Year 4 Public Health Workshop in O&G.
Jolene Johnson, MD Associate Clinical Professor of Medicine, LSU School of Medicine Head, Statewide Diabetes Disease Management, LSU HCSD Diabetes Disease.
Public Health Perspective on Radon Control in Ireland Dr. Ina Kelly Specialist Registrar in Public Health Medicine Health Service Executive Department.
Principles of Outbreak Management
Hyperbilirubinemia: Discussion Alexis Thompson, MD Catherine Wicklund, MS, CGC.
Potential Roles and Limitations of Biomarkers in Alzheimer’s Disease Richard Mayeux, MD, MSc Columbia University.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
Thoughts on Biomarker Discovery and Validation Karla Ballman, Ph.D. Division of Biostatistics October 29, 2007.
Dr Don Ajith Karawita MBBS, PgD Ven, MD Venereology National STD/AIDS Control Programme.
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
Screening Sherine Shawky, MD, Dr.PH Assistant Professor Public Health King Abdulaziz University College of Medicine
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
Uses and Abuses of Screening Tests Screening tests are ubiquitous in practice Principles of screening are widely misunderstood Goal of screening is to.
Cervical screening Tim Wright Sept 07. Introduction What who when What who when Benefits (evidence) Benefits (evidence) Cost Cost Does it fit wilson’s.
The Nature of Disease.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
EPIB-591 Screening Jean-François Boivin 29 September
Screening Dr Gerry Bryant. What is screening? Systematic application of a test or enquiry, to identify individuals at sufficient risk of a specific disorder.
Aortic Aneurysm Screening
Screening Introduction to Primary Care:
Regulatory criteria for approval Bob Craig, July 2007.
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Saudi Diploma in Family Medicine / 24 1 Dr. Zekeriya Aktürk Preventive Medicine and Periodic Health Examinations in Primary Care.
Dr K N Prasad Community Medicine
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Clinical Writing for Interventional Cardiologists.
Screening Puja Myles
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Cost-effectiveness of Screening Tests Mark Hlatky, MD Stanford University.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
SCREENING TTTThe search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy.
Principles of Screening
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
SINGING FROM THE SAME HYMN SHEET Address to SATS Study Day 29 June 2013 Dr Sue Armstrong.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
Estie Vermeulen Screening. Definition Screening is the organized attempt to detect, among apparently healthy people in the community, disorders or risk.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Lesson 3 Page 1 of 24 Lesson 3 Considerations in Planning Public Health Surveillance.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
دکتر حمیدرضا صابری
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Cancer prevention and early detection
Some epidemiological principles and methods
Cancer prevention and early detection
Evidence Based Screening
Principles of Epidemiology E
Class session 7 Screening, validity, reliability
Comunicación y Gerencia
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
How do we delay disease progress once it has started?
Breast Cancer SKRINING
Newborn screening Dr Jim Bonham Clinical Director
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Screening, Sensitivity, Specificity, and ROC curves
Dr. Hannah Jordan Lecturer in Public Health ScHARR
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
No matter what the type of genetic screening, certain core principles should be followed before a program is introduced. Principles of Screening • The.
Presentation transcript:

Screening in arterial disease: ethical and methodological issues P Lacroix and V Aboyans

Screening: definition « Tests done among apparently well people to identify those at an increased risk of a disease or disorder » Implying in case of positive test:  Subsequent diagnostic test or procedure  And/or treatment Resulting in health improvement or harms…

Screening: potential harms Population: Healthy people (without any complains)  For the subject Psychological costs of screening? Every adverse outcome : iatrogenic and preventable  Economical issues: cost for the society  Test performances and population selection

Questions that matter to the subject  What is my risk of dying of this disease if: I choose not to be screened? I choose to be screened?  What is my chance for having an “abnormal” screening test result?  If my screening test result is abnormal: what follow-up tests will I need? what is my chance of having the disease?  If my screening test result is normal what is my chance of having the disease anyway? Goyder E et al. J Med Screen 2000;7:123-6

Psychological issue after the test?  Normal Test  Abnormal Test implying a specific treatment  Abnormal Test implying a follow-up  Abnormal Test without any change

Mason JM et al. J Public Health Med 1993;15:154–60 Population screening for abdominal aortic aneurysm Decision tree structure

Key points in running a screening programme  Prepare a written protocol covering all aspects of screening  Train staff  Issue motivating – not threatening – invitations and reminders  Give information orally and in writing before the test  Inform all the patients of their results  Follow up all patients with positive results  Evaluate both epidemiological and psychological outcomes of the programme Marteau T M BMJ 1990;301:26-8

Criteria for a screening  The disease Importance of the disease? Clear definition of the disease? Prevalence well known?  The policy Programme cost effective? Facilities for diagnosis and treatment available? Course of action after a positive result acceptable?  The test Safe, valid and reliable? Grimes DA et al. The Lancet 2002;359:881-4

Test effectiveness? Test performances AAA Echography: cut off ? … PAD pulse palpation? ABI: Methods? Cut off? Calculation mode?… Carotid stenosis Duplex performances? In most of these situations: dichotomous results (normal-abnormal)

Test effectiveness? Influence of the population PPV VPV Varying with the prevalence of the disease in the population

Setting of the test Duplex and DVT  Suspicion of DVT : symptomatic patients High performances included in a strategy  Screening : asymptomatic subjects Low isolated performances

Misclassification  False negative False reassurance  False positive The high sensitivity in order to reduce the risk false negative is often associated with a low specificity and PPV; it results in: Anxiety Further investigations with possible adverse events

4 criteria for an optimal screening (1) The condition: important, and the natural history and epidemiology must be understood. The screening test: simple, safe, precise and acceptable to the general population, and defined diagnostic process following a positive test. Treatment: should lead to better outcomes than treatment provided at the point of clinical diagnosis.

4 criteria for an optimal screening (2) Screening programme: should be defined, adequate staffing and facilities should be available to cope with expected demand the programme should provide value for money, as compared with other areas of medical expenditure. screening programme should be cost-effective (and if cost-effective, the most cost-effective form of screening should be implemented).